Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Prymula

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
The Pediatric Infectious Disease Journal|May 16, 2018
Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech RepublicRoman Prymula, Dorothee Kieninger, Emmanuel Feroldi, et al.
Health Economics Review|April 15, 2026
Socioeconomic barriers to healthcare cost-sharing in the Czech Republic: limited awareness and resistanceJan Hodač, Drahomíra Holmannová, Eva Čermáková, et al.
Vaccine|July 5, 2015
Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old childrenTimo Vesikari, Roman Prymula, Elizabeth Merrall, et al.
Vaccine|July 8, 2008
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccinesRoman Prymula, Roman Chlibek, Miroslav Splino, et al.
Travel Medicine and Infectious Disease|November 2, 2013
A repeated syphilis infection imported from Thailand in an HIV positive couple of men-who-have-sex-with-men in Czech RepublicMiloslav Salavec, Vanda Bostik, Jaroslav Kapla, et al.
Current Medicinal Chemistry|August 22, 2015
Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR AgonistsJan Honegr, Ondrej Soukup, Rafael Doležal, et al.
Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)|February 1, 2008
Medialization thyroplasty with a customized silicone implant: clinical experienceViktor Chrobok, Arnost Pellant, Frantisek Sram, et al.
Journal of Paediatrics and Child Health|November 15, 2018
Comparison of vaccination coverage of four childhood vaccines in New Zealand and New York StateKatherine E Baumann, Janine Paynter, Helen Petousis-Harris, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, et al.
Lancet (London, England)|January 18, 2013
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trialsTimo Vesikari, Susanna Esposito, Roman Prymula, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
The Pediatric Infectious Disease Journal|May 16, 2018
Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech RepublicRoman Prymula, Dorothee Kieninger, Emmanuel Feroldi, et al.
Health Economics Review|April 15, 2026
Socioeconomic barriers to healthcare cost-sharing in the Czech Republic: limited awareness and resistanceJan Hodač, Drahomíra Holmannová, Eva Čermáková, et al.
Vaccine|July 5, 2015
Meningococcal serogroup B vaccine (4CMenB): Booster dose in previously vaccinated infants and primary vaccination in toddlers and two-year-old childrenTimo Vesikari, Roman Prymula, Elizabeth Merrall, et al.
Vaccine|July 8, 2008
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccinesRoman Prymula, Roman Chlibek, Miroslav Splino, et al.
Travel Medicine and Infectious Disease|November 2, 2013
A repeated syphilis infection imported from Thailand in an HIV positive couple of men-who-have-sex-with-men in Czech RepublicMiloslav Salavec, Vanda Bostik, Jaroslav Kapla, et al.
Current Medicinal Chemistry|August 22, 2015
Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR AgonistsJan Honegr, Ondrej Soukup, Rafael Doležal, et al.
Folia Phoniatrica Et Logopaedica : Official Organ of the International Association of Logopedics and Phoniatrics (IALP)|February 1, 2008
Medialization thyroplasty with a customized silicone implant: clinical experienceViktor Chrobok, Arnost Pellant, Frantisek Sram, et al.
Journal of Paediatrics and Child Health|November 15, 2018
Comparison of vaccination coverage of four childhood vaccines in New Zealand and New York StateKatherine E Baumann, Janine Paynter, Helen Petousis-Harris, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I)Roman Prymula, Susanna Esposito, Gian Vincenzo Zuccotti, et al.
Lancet (London, England)|January 18, 2013
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trialsTimo Vesikari, Susanna Esposito, Roman Prymula, et al.
Pageof 8